Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study.

International journal of immunopathology and pharmacology

Volumn 23, Issue 4, 2010, Pages 1185-1194

  Giordano, N ^a   Puccetti, L ^b   Papakostas, P ^b   Di Pietra, N ^b   Bruni, F ^b   Pasqui, A L ^b   Acampa, M ^b   Bocchi, V ^b   Donati, V ^b   Voglino, M ^b   Fioravanti, A ^b   Montella, A ^b   Auteri, A ^b   Nuti, R ^b   Pastorelli, M ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ENDOTHELIN RECEPTOR; SULFONAMIDE;

AGED; ARTICLE; DRUG ANTAGONISM; FEMALE; FIBROSIS; HUMAN; IDIOPATHIC PULMONARY HYPERTENSION; MALE; MIDDLE AGED; PATHOLOGY; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; SKIN; SYSTEMIC SCLEROSIS;

AGED; FEMALE; FIBROSIS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; RAYNAUD DISEASE; RECEPTORS, ENDOTHELIN; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SKIN; SULFONAMIDES;

MLCS; MLOWN;

EID: 79953012052     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300422     Document Type: Article

References (0)